The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...
The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
MedPage Today on MSN
FDA says to drop suicide warning from GLP-1 drug labels
Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
America is in the midst of a pharmacy crisis, and the Food and Drug Administration could make it much worse. Hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback